Literature DB >> 2119362

Okadaic acid and phorbol esters: comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro.

F Katoh1, D J Fitzgerald, L Giroldi, H Fujiki, T Sugimura, H Yamasaki.   

Abstract

Okadaic acid is a non-12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoter in the mouse skin carcinogenesis system. Here we report on the in vitro activity of okadaic acid in 3 assay systems: BALB/c 3T3 cell transformation, gap junctional intercellular communication (GJIC) in various cell types, and inhibition of induction of differentiation of Friend virus-transformed murine erythroleukemia (MEL) cells. The activity of okadaic acid was compared to that of the phorbol ester tumor promoters TPA and phorbol-12,13-didecanoate (PDD). In a test system involving a 2-week exposure of BALB/c 3T3 cells following 3-methylcholanthrene initiation, okadaic acid at a concentration of 10 ng/ml was equipotent to PDD as a promoter of cell transformation (4.9 and 3.7 foci/dish, respectively). Longer exposures to okadaic acid resulted in cytotoxicity. Okadaic acid-generated as well as PDD-generated transformed foci displayed a selective lack of GJIC between focus cells and surrounding normal cells, i.e., transformed cells communicate among themselves but not with surrounding cells. However, in contrast to TPA, there was no inhibition by okadaic acid, except at toxic doses, of homologous GJIC in BALB/c 3T3 cells or human and mouse keratinocytes. Furthermore, okadaic acid, unlike TPA, did not inhibit MEL cell differentiation. Together, these results indicate that okadaic acid acts as a promoter of cell transformation but that its mechanism of action is different from that of the phorbol ester tumor promoters.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119362      PMCID: PMC6504065          DOI: 10.1111/j.1349-7006.1990.tb02614.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  8 in total

1.  Induction of minisatellite mutation in NIH 3T3 cells by treatment with the tumor promoter okadaic acid.

Authors:  H Nakagama; S Kaneko; H Shima; H Inamori; H Fukuda; R Kominami; T Sugimura; M Nagao
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

2.  SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.

Authors:  Dale J Christensen; Youwei Chen; Jessica Oddo; Karen M Matta; Jessica Neil; Evan D Davis; Alicia D Volkheimer; Mark C Lanasa; Daphne R Friedman; Barbara K Goodman; Jon P Gockerman; Louis F Diehl; Carlos M de Castro; Joseph O Moore; Michael P Vitek; J Brice Weinberg
Journal:  Blood       Date:  2011-08-15       Impact factor: 22.113

Review 3.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

4.  Effects of okadaic acid on cell growth, anchorage-independent growth, and co-cultures of normal (KMS-6), immortalized (KMST-6), and neoplastically transformed (KMST-6T and KMST-6/RAS) human fibroblasts.

Authors:  I Jahan; M Iijima; T Kondo; M Namba
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 5.  Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication.

Authors:  I V Budunova; G M Williams
Journal:  Cell Biol Toxicol       Date:  1994-04       Impact factor: 6.691

6.  Epidermal growth factor stimulates the disruption of gap junctional communication and connexin43 phosphorylation independent of 12-0-tetradecanoylphorbol 13-acetate-sensitive protein kinase C: the possible involvement of mitogen-activated protein kinase.

Authors:  M Y Kanemitsu; A F Lau
Journal:  Mol Biol Cell       Date:  1993-08       Impact factor: 4.138

Review 7.  Aberrant expression and function of gap junctions during carcinogenesis.

Authors:  H Yamasaki
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

8.  Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1.

Authors:  A Sakai; H Fujiki
Journal:  Jpn J Cancer Res       Date:  1991-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.